International Meeting of World Pharmacopoeias, 18-19 April 2013, New Delhi
The second international meeting of world
pharmacopoeias was jointly hosted by the World Health Organization and Indian
Pharmacopeia Commission, Ministry of Health & Family
Welfare, Government of India on 18-19 April 2013, in New Delhi, India.
Various WHO Member States’ pharmacopoeias
worldwide attended this meeting as partners and deliberated on important
issues of common interest, including the follow-up of the recommendations
expressed during the first international meeting of world pharmacopoeias.
During the meeting, a revised draft of a new guideline on good pharmacopoeial practices (GPhP) was also deliberated upon with the
Positioned as a strategic policy dialogue, the
outcomes and recommendations of this meeting will be presented to the WHO
Expert Committee on Specifications for Pharmaceutical Preparations, which
advises the Director-General, WHO and WHO's Member States on future
perspectives and strategic approaches in relation to pharmacopoeias.
To know more, please visit: http://www.wpm2013india.com/index.html
India’s National Regulatory Authority meets
international standards for vaccine regulations
The National Regulatory Authority of India (NRA)
and affiliated institutions meet WHO published indicators for a functional
vaccine regulatory system. A WHO-led team of
international experts from eight countries came to this conclusion at the end
of a comprehensive review from 10-14 December 2012.
“The Central Drugs Standards Control Organization
in collaboration with WHO, has made exemplary
efforts towards this achievement. The Government of India has decided to
further strengthen the Central as well as the State Drugs Regulatory Systems
during the 12th Five Year Plan (2012-17) and looks forward to strengthening
our collaboration with WHO towards this end,” said Shri Ghulam Nabi
Azad, Minister, Health & Family welfare,
Government of India.
India is a major vaccine producer that has 12 major
vaccine manufacturing facilities. These vaccines are used for the national
and international market (150 countries), which makes India a major
vaccine supplier across the globe. More than 70% of all measles vaccines used
globally are produced in India. More >..
Scaling up action on hypertension and
related comorbidities in India
On 4 April, WHO Country Office for India, in collaboration with the Ministry of
Health and Family Welfare (MoHFW),
Government of India convened a national consultation
in Delhi to
celebrate World Health Day 2013.
In keeping with this year’s theme, the event focussed
on “Scaling up action on hypertension and related comorbidities
Mr Keshav Desiraju,
Secretary, Health & Family Welfare, Government of India delivered the
inaugural address. Other speakers at the inaugural session were Dr Jagdish Prasad, Director General of Health Services and
Dr Nata Menabde, WHO
Representative to India.
Also present on the occasion was Mr Anshu Prakash, Joint Secretary,
Ministry of Health and Family Welfare, Government of India.
The event covered the rising
prevalence of hypertension and other NCDs in India,
population-based prevention of risk factors, improving the treatment and
management of hypertension and related comorbidities, necessary
integration of services and continuum of care, and the efforts of the
national and state authorities, WHO and partners in taking an integrated
approach to NCDs including hypertension. All these
issues were discussed in the context of overarching agenda of universal health coverage. More >…
World Health Day 2013
Health Day is celebrated on 7 April to mark the anniversary of the founding
of WHO in 1948. Each year a theme is selected for
World Health Day that highlights a priority area of public health concern in
for 2013 is high blood pressure.
or high blood pressure is estimated to cause 7.5 million deaths, about 12.8%
of the total of all deaths. This accounts for 57 million disability adjusted
life years (DALYS) or 3.7% of total DALYS. One in three adults worldwide has
high blood pressure. The proportion increases with age, from 1 in 10 people
in their 20s and 30s to 5 in 10 people in their 50s. It increases the risk of
heart attacks, strokes, kidney failure and many other
associated comorbidities. Treating raised
blood pressure and maintaining it below 140/90 mmHg is associated with a
reduction in cardiovascular complications.
Office for India
is utilizing this opportunity to explore and identify how the health system
can be strengthened across the continuum of care, to address hypertension and
associated comorbidities with other noncommunicable diseases (NCDs)
and with communicable diseases (CDs). Due attention would be given to issues
including a primary health care approach; improved diagnostic capacity;
access to essential medicines; capacity building of staff; strengthening the
Health Information System to capture data on NCDs
and associated comorbidities; engaging the private
and voluntary sectors to address hypertension, and linkages to both, the coverage and financial protection aspects of universal health coverage. More >..
Mumbai Mission for TB Control -
Towards universal access to TB care
Resistant TB (MDR TB) in Mumbai was brought into sharp focus in January 2012
with reports of the so called incurable Totally Drug Resistant TB (TDR
TB). The Municipal Corporation of Greater Mumbai (MCGM) took up the challenge
in right earnest. Through improved diagnostics and strategies, the detection
of MDR TB went up from 53 cases in 2010 to 2429 cases in 2012. The year 2012
also saw a substantial strengthening of the TB control programme in the
city in terms of infrastructure, diagnostics and treatment capacities.
2013, a workshop was held in Mumbai facilitated by WHO
to develop a comprehensive plan for further scaling up TB care in the city.
The resultant plan, ‘Mumbai Mission for TB Control’ was released by the Mayor
of Mumbai, Mr Sunil Prabhu on 22 March 2013 at a
function attended by Dr Nata Menabde,
WHO Representative to India.
Also present on the occasion were Mr Sitaram Kunte, Municipal Commissioner; Ms Manisha
Mhaiskar Additional Municipal Commissioner; Dr A Bamne, Executive Health Officer; Dr Minne
Khetarpal, City TB Officer; elected representatives of MCGM, other senior officials and media. More >…
Health Minister launches WHO India’s
New Country Cooperation Strategy
better health for all Indians, Mr Ghulam Nabi Azad, the Hon’ble Minister for
Health & Family Welfare, Government of India launched WHO’s new Country
Cooperation Strategy with India
(2012-17) along with Dr Nata Menabde, WHO Representative to India on 29 June 2012.
Present at the launch were Mr P K Pradhan,
Secretary, Ministry of Health & Family Welfare (MoHFW);
Mr K Desiraju, Special Secretary (Health
Administration), MoHFW; and development partners
including representatives from other UN agencies, World Bank, USAID, CDC,
Norway India Partnership Initiative and Rotary International.
the shared vision of the two partners, it is for the first time that the
Country Cooperation Strategy (CCS) has been developed jointly by the Ministry
of Health and Family Welfare (MoHFW), Government of
India and the WHO Country Office for India (WCO).